DIAMEDICA THERAPEUTICS INC (DMAC) Stock Cash Flow
NASDAQ:DMAC - Nasdaq - CA25253X2077 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.44M | -19.38M | -13.68M | -13.59M | -12.29M | |||
| Depreciation Amortization | 39.00K | 30.00K | 25.00K | 24.00K | 21.00K | |||
| Change In Working Capital | 1.51M | 93.00K | 585.00K | -461.00K | 1.20M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 2.00K | |||
| Taxes Paid | 26.00K | 33.00K | 27.00K | 28.00K | 36.00K | |||
| Other non cash items | 817.00K | 530.00K | 1.55M | 1.78M | 1.89M | |||
| OPERATING CASH FLOW | -22.08M | -18.73M | -11.51M | -12.25M | -9.19M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -25.00K | -24.00K | -81.00K | -22.00K | -47.00K | |||
| Other Investing Activity | 8.59M | -18.27M | 11.62M | -20.52M | -16.09M | |||
| INVESTING CASH FLOW | 8.56M | -18.30M | 11.54M | -20.54M | -16.13M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.00K | -6.00K | -6.00K | -6.00K | -5.00K | |||
| Stock Issued/Repurchased | 12.00M | 36.85M | 0.00 | 30.09M | 28.85M | |||
| FINANCING CASH FLOW | 11.99M | 36.84M | -6.00K | 30.09M | 28.84M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -1.52M | -185.00K | 21.00K | -2.70M | 3.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.08M | -18.73M | -11.51M | -12.25M | -9.19M | |||
| Capital Expenditure | -25.00K | -24.00K | -81.00K | -22.00K | -47.00K | |||
| FREE CASH FLOW | -22.10M | -18.75M | -11.59M | -12.27M | -9.23M | |||
All data in USD